MetLife Investment Advisors »

Apellis Pharmaceuticals shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $367k 6.1k 59.86
2023-09-30 $233k 6.1k 38.04
2023-06-30 $558k 6.1k 91.10
2023-03-31 $3.2M 49k 65.96
2022-12-31 $2.6M 50k 51.71
2022-09-30 $3.4M 50k 68.30
2022-06-30 $2.1M 47k 45.22
2022-03-31 $2.1M 41k 50.81
2021-12-31 $1.2M 25k 47.28
2021-09-30 $798k 24k 32.96
2021-06-30 $1.5M 24k 63.20
2021-03-31 $1.0M 24k 42.91
2020-12-31 $1.4M 24k 57.19
2020-09-30 $807k 27k 30.17
2020-06-30 $874k 27k 32.67
2020-03-31 $680k 25k 26.79
2019-12-31 $683k 22k 30.62
2019-09-30 $537k 22k 24.09
2019-06-30 $438k 17k 25.32
2019-03-31 $337k 17k 19.50
2018-12-31 $228k 17k 13.19
2018-09-30 $477k 27k 17.77
2018-03-31 $126k 5.7k 22.04